Trésor-Economics No. 145 - What is the future of France's healthcare expenditure reimbursement system for patients with long-standing diseases?
Expenditure for patients suffering from a recognized long-standing diseases(Affection de Longue Durée - ALD) currently represents a major share (€90bn in 2011) of total reimbursed healthcare expenditures. The ALD system itself, which supplements standard reimbursements by granting patients copayment exempt status for all medical procedures and services related to LSDs, costs the national health in... Lire la suite